Drug Profile


Alternative Names: SR 49059

Latest Information Update: 03 Oct 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sanofi-Synthelabo
  • Class Antihormones; Indoles; Pyrrolidines; Vasodilators
  • Mechanism of Action Vasopressin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Coronary spasm; Dysmenorrhoea; Heart failure; Hypertension; Preterm labour; Small cell lung cancer

Most Recent Events

  • 10 Sep 2003 Discontinued - Phase-II for Small cell lung cancer in France (PO)
  • 10 Sep 2003 Discontinued - Preclinical for Coronary spasm in France (PO)
  • 04 Sep 2001 Discontinued-Clinical for Preterm labour in Poland (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top